Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma
O'Donoghue, J.A.; Wheldon, T.E.; Babich, J.W.; Moyes, J.S.; Barrett, A.; Meller, S.T.
Progress in Clinical and Biological Research 366: 455-461
1991
ISSN/ISBN: 0361-7742 PMID: 2068160 Document Number: 386538
Document emailed within 1 workday
Related Documents
Liu, B.; Zhuang, H.; Servaes, S. 2013: Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 21-28Tsuchimochi, S.; Nakajo, M.; Nakabeppu, Y.; Tani, A. 1997: Metastatic pulmonary pheochromocytomas: positive I-123 MIBG SPECT with negative I-131 MIBG and equivocal I-123 MIBG planar imaging Clinical Nuclear Medicine 22(10): 687-690
Aktolun, C.; Castellani, M.R. 2013: Theranostic role of MIBG in neuroblastoma Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 3-5
Hocken, D.B.; McCollum, C.N. 1990: Peri-operative uptake of radiolabelled platelets in the lungs Progress in Clinical and Biological Research 355: 17-21
Rutgers, M.; Gubbels, A.A.; Hoefnagel, C.A.; Voûte, P.A.; Smets, L.A. 1991: A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy Progress in Clinical and Biological Research 366: 471-478
Martins, E.; Faria, T.; Silva-Cardoso, J.; Oliveira, A.; Campelo, M.; Amorim, S.; Moura, B.; Rocha-Gonçalves, F.; Pereira, J.G.; Maciel, M.J.úl. 2009: I-123-MIBG cardiac uptake imaging, in familial dilated cardiomyopathy Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 28(1): 29-36
Lumbroso, J.D.; Guermazi, F.; Hartmann, O.; Coornaert, S.; Rabarison, Y.; Leclère, J.G.; Couanet, D.; Bayle, C.; Caillaud, J.M.; Lemerle, J. 1988: Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans Progress in Clinical and Biological Research 271: 689-705
Weissman, A.F.; Gonzalez, C.E.; Shapiro, B.; Shulkin, B.; Francis, I.R.; Leach, K. 1994: Multiple chemodectomas. Carotid body tumor masked by salivary gland uptake on I-123 MIBG scintigraphy Clinical Nuclear Medicine 19(6): 527-531
Lewis, I.J.; Lashford, L.S.; Fielding, S.; Flower, M.A.; Ackery, D.; Kemshead, J. 1991: A phase I/Ii study of 131i mIBG in chemo-resistant neuroblastoma. the United Kingdom Children's Cancer Study Group (UKCCSG) Progress in Clinical and Biological Research 366: 463-469
Hattner, R.S.; Pounds, T.R.; Matthay, K.K. 1994: Normal cerebellar MIBG localization. Implications in the interpretation of delayed scans Clinical Nuclear Medicine 19(11): 985-988
Samnick, S.; Kirsch, C.M. 1999: A simple and rapid routine preparation of no-carrier added meta-I-123- and I-131-iodobenzylguanidine (I-123-MIBG and I-131-MIBG) for clinical nuclear medicine applications Nuklearmedizin. Nuclear Medicine 38(7): 292-296
Jindahra, P.; Vejjajiva, A.; Witoonpanich, R.; Sirisriro, R.; Sritara, C.; Pulkes, T. 2004: Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report) Journal of the Medical Association of Thailand 87(10): 1176-1181
Montaldo, P.G.; Carbone, R.; Lanciotti, M.; Ponzoni, M.; Cornaglia-Ferraris, P. 1991: In vitro pharmacology of metaiodobenzylguanidine uptake, storage and release in human neuroblastoma cells Journal of Nuclear Biology and Medicine 35(4): 195-198
Osmers, F.; Schnepper, E. 1973: Diagnostic and therapeutic aspects of neuroblastoma sympathicum Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 1973(0 Suppl): 184-185
Konjević, G.; Jović, V.; Radulović, S.; Jelić, S.; Dzodić, R.; Spuzić, I. 2001: Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha Neoplasma 48(3): 175-181
Rubie, H.; Hartmann, O.; Giron, A.; Lemoine, G.; Guitard, J.; Robert, A.; Lemerle, J. 1990: Localized thoracic neuroblastoma: the role of surgery and therapeutic results. Apropos of 40 cases Chirurgie Pediatrique 31(3): 146-151
Byfield, J.E. 1976: Therapeutic relationships between DNA synthesis and repair, membrane differentiation, and organ-specific immunotherapy in neuroblastoma Progress in Clinical and Biological Research 9: 73-87
Traber, J.; Fischer, K.; Latzin, S.; Hamprecht, B. 1975: Morphine antagonises action of prostaglandin in neuroblastoma and neuroblastoma times glioma hybrid cells Nature 253(5487): 120-122
Baskin, F.; Carlin, S.C.; Kraus, P.; Friedkin, M.; Rosenberg, R.N. 1975: Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma Molecular Pharmacology 11(1): 105-117
Ikeda, H.; Nagashima, K.; Matsuyama, S.; Okumura, H.; Nagamachi, Y. 1988: Multidisciplinary treatment of advanced neuroblastoma--experience in treatment with the protocol of a group study supported by a grant from Ministry of Health and Welfare Gan No Rinsho. Japan Journal of Cancer Clinics 34(8): 953-960